Journal of Otology & RhinologyISSN: 2324-8785

Reach Us +1 850 754 6199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report, J Otol Rhinol Vol: 3 Issue: 6

Successful Treatment of Maxillary Mucormycosis: Report of a Case and Literature Review

Ayman F. Hegab*
Department of Oral & Maxillofacial Surgery, Faculty of Dental Medicine, Al-Azhar University,Cairo, Egypt
*Corresponding author : Dr. Ayman F. Hegab
Associate Professor, Department of Oral & Maxillofacial Surgery, Faculty of Dental Medicine, Al-Azhar University,Cairo, Egypt
Tel: 0097433310124
E-mail: [email protected]
Received: June 25, 2014 Accepted: October 31, 2014 Published: December 05, 2014
Citation: Hegab FA (2014) Successful Treatment of Maxillary Mucormycosis: Report of a Case and Literature Review. J Otol Rhinol 3:6. doi:10.4172/2324-8785.1000197

Abstract

Successful Treatment of Maxillary Mucormycosis: Report of a Case and Literature Review

Opportunistic fungal infections, such as mucormycosis, often occur in immunocompromised patients. Predisposing conditions include metabolic disorders (e.g. uncontrolled diabetes), corticosteroid or immunosuppressive therapy, desferoxamine therapy, burns, solid organ or bone marrow transplants, or neutropenic hematologic malignant diseases and their corresponding treatment. The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores. The infection can spread to orbital and intracranial structures either by direct invasion or through the blood vessels. The fungus invades the arteries leading to thrombosis that subsequently causes necrosis of hard and soft tissues. We report a case of maxillary necrosis by mucormycosis in an uncontrolled diabetic patient and its successful treatment to emphasize that early diagnosis and prompt treatment can reduce the mortality and morbidity of this lethal fungal infection.

Keywords: Maxillary mucormycosis; Immunosuppressive therapy; Phycomysosis

Track Your Manuscript

Share This Page

Media Partners

Associations